Baricitinib 4 mg/1
baricitinib · TABLET, FILM COATED · Eli Lilly and Company
No Recall History
Plain English
Baricitinib is a tablet, film coated containing baricitinib at 4 mg/1, taken oral. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Baricitinib
- Generic Name
- baricitinib
- NDC Code (Product)
0002-6885- Manufacturer
- Eli Lilly and Company
- Strength
- 4 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Drug Class
- Janus Kinase Inhibitor [EPC]
- Marketing Start
- 12/20/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
off label use385 reports
drug ineffective311 reports
covid-19172 reports
pulmonary embolism163 reports
pneumonia134 reports
rheumatoid arthritis123 reports
deep vein thrombosis119 reports
death102 reports
condition aggravated100 reports
drug ineffective for unapproved indication87 reports
Frequently Asked Questions
What is Baricitinib used for?
Baricitinib contains baricitinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Baricitinib a controlled substance?
Baricitinib is not classified as a controlled substance by the DEA.
What is the generic name for Baricitinib?
The generic name for Baricitinib is baricitinib. There are 3 other brand versions of baricitinib.
What is the NDC code for Baricitinib 4 mg/1?
The NDC (National Drug Code) for Baricitinib 4 mg/1 is 0002-6885, listed by Eli Lilly and Company.